Trexquant Investment LP Oramed Pharmaceuticals Inc. Transaction History

Trexquant Investment LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$8.19 - $13.89 $99,000 - $167,902	-12,088 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$12.98 - $29.75 $12,512 - $28,679	964 Added 8.67%	12,088 $173,000
Q3 2021 Nov 12, 2021	BUY	$12.13 - $23.82 $134,934 - $264,973	11,124 New	11,124 $245,000

7.4M

2.1K

Ticker ORMP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,827,100
Market Cap $92.4M
Description
Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the treatment of diabetes and for the use of orally ingestible capsules or pills for delivery of polypeptides. Its proprietary flagship product is the ORMD-0801, an orally ingestible insulin capsule, which completed phase II clinical trials for th...

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

Stay updated on Trexquant Investment LP with notifications on news.